These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36133588)

  • 1. Mesoporous silica-based hybrid materials for bone-specific drug delivery.
    Pasqua L; De Napoli IE; De Santo M; Greco M; Catizzone E; Lombardo D; Montera G; Comandè A; Nigro A; Morelli C; Leggio A
    Nanoscale Adv; 2019 Aug; 1(8):3269-3278. PubMed ID: 36133588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
    Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
    Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y; Wang B; Chen J; He J; Qiu X
    Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of the crystal growth of mesoporous silica nanoparticles and the evaluation to ibuprofen loading and release.
    Kamarudin NH; Jalil AA; Triwahyono S; Artika V; Salleh NF; Karim AH; Jaafar NF; Sazegar MR; Mukti RR; Hameed BH; Johari A
    J Colloid Interface Sci; 2014 May; 421():6-13. PubMed ID: 24594025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxymethyl Cellulose-Grafted Mesoporous Silica Hybrid Nanogels for Enhanced Cellular Uptake and Release of Curcumin.
    Tiwari N; Nawale L; Sarkar D; Badiger MV
    Gels; 2017 Feb; 3(1):. PubMed ID: 30920505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
    Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
    Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
    Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers.
    Wang Y; Han N; Zhao Q; Bai L; Li J; Jiang T; Wang S
    Eur J Pharm Sci; 2015 May; 72():12-20. PubMed ID: 25701727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and photophysical properties of rare-earth complexes encapsulated into surface modified mesoporous silica nanoparticles.
    Malba C; Sudhakaran UP; Borsacchi S; Geppi M; Enrichi F; Natile MM; Armelao L; Finotto T; Marin R; Riello P; Benedetti A
    Dalton Trans; 2014 Nov; 43(43):16183-96. PubMed ID: 24874265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Shape on Mesoporous Silica Nanoparticles for Oral Delivery of Indomethacin.
    Zhang W; Zheng N; Chen L; Xie L; Cui M; Li S; Xu L
    Pharmaceutics; 2018 Dec; 11(1):. PubMed ID: 30583601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-Sensitive Polyacrylic Acid-Gated Mesoporous Silica Nanocarrier Incorporated with Calcium Ions for Controlled Drug Release.
    Kong J; Park SS; Ha CS
    Materials (Basel); 2022 Aug; 15(17):. PubMed ID: 36079309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
    Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Biocompatible Mesoporous Silica/Polysaccharide Hybrid Materials as Possible Drug Delivery Systems.
    Pandele AM; Andronescu C; Ghebaur A; Garea SA; Iovu H
    Materials (Basel); 2018 Dec; 12(1):. PubMed ID: 30577550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system.
    Wu L; Gou K; Guo X; Guo Y; Chen M; Hou J; Li S; Li H
    Colloids Surf B Biointerfaces; 2021 Mar; 199():111501. PubMed ID: 33338882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid Mesoporous Silica-Based Drug Carrier Nanostructures with Improved Degradability by Hydroxyapatite.
    Hao X; Hu X; Zhang C; Chen S; Li Z; Yang X; Liu H; Jia G; Liu D; Ge K; Liang XJ; Zhang J
    ACS Nano; 2015 Oct; 9(10):9614-25. PubMed ID: 26316321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
    Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
    Thiyagarajan V; Lin SX; Lee CH; Weng CF
    Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.